This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
03/31/15 - 3:59:43 PM ET (BATS BZX Real-time Price)
Div Yield: --
NLNK Day's Range
NLNK 52 Week Range
NLNK Business Summary
NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer.View NLNK key stats
NewLink Genetics Corp - NLNK - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates NewLink Genetics Corp as a
Hold with a ratings score of C+.
Report Snippet: We rate NewLink Genetics Corp (NLNK) a Hold.
This is based on the convergence of positive investment measures, which should help this stock outperform the majority
of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance,
growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company
may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.